BillionToOne sells genetic blood tests for prenatal screening and cancer care to doctors and clinics. It last closed at $89.92 on Nov 20, down 0.31% on the day. The next earnings report for BLLN is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, BLLN reported EPS of $0.32 on revenue of $123.0M, with revenue up 47.2% from a year ago. Over its last 6 reports the stock moved an average of 14.3% the session after earnings. Over the last 12 months BLLN insiders bought $0 of stock on the open market and sold $58.5M, according to SEC Form 4 filings.
AI Auto Pilots
Is BLLN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BLLN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on BLLNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
BLLN · as of the Nov 20 close · updated each morning
Turning down, nearing oversold
The stock is 19% below its 20 day and 18% below its 50 day average. It is 9% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 30), near oversold. The nearest support is the Pivot at $89.78, and the nearest resistance the Pivot R1 at $91.57.
Short trendBearish
Long trendNeutral
MomentumWeak
StretchNear oversold
VolatilityNormal, 7.3%/day
Key levels
$150.4452 week high+67.3%
$109.23100 day average+21.5%
$107.3720 day average+19.4%
$106.4050 day average+18.3%
$100.00Swing high (May 29)+11.2%
$97.90200 day average+8.9%
$91.57Pivot R1+1.8%
$89.92Last close
$89.78Pivot−0.2%
$89.78Swing low (Aug 31)−0.2%
$88.14Pivot S1−2.0%
$61.9652 week low−31.1%
Indicators
RSI (14)
30.06
Weak, oversold below 30
Neutral
MACD
-3.65
Below its signal line
Bearish
Stochastic
15.1
Near the bottom of its range
Oversold
ADX (14)
22.6
Weak trend
Williams %R
-86.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-170.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−21.1%
Change over 10 sessions
Bearish
ATR (14)
$6.60
Typical daily range, 7.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityNormal, 18.0%/day
Key levels
$150.4452 week high+67.3%
$109.23100 day average+21.5%
$107.3720 day average+19.4%
$106.4050 day average+18.3%
$100.00Swing high (May 29)+11.2%
$97.90200 day average+8.9%
$91.57Pivot R1+1.8%
$89.92Last close
$89.78Pivot−0.2%
$89.78Swing low (Aug 31)−0.2%
$88.14Pivot S1−2.0%
$61.9652 week low−31.1%
Indicators
RSI (14)
43.58
Middle of its range
Neutral
MACD
0.66
Below its signal line
Bearish
Stochastic
31.6
Middle of its range
Neutral
ADX (14)
19.3
No clear trend
Williams %R
-89.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-97.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−9.0%
Change over 10 sessions
Bearish
ATR (14)
$16.17
Typical daily range, 18.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for BLLN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BLLN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for BLLNHow many large options trades hit BLLN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in BLLN in the last 90 days.
From SEC Form 4 filings by BLLN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BLLN is in one of them and how their past BLLN trades turned out.
BillionToOne is a molecular diagnostics company based in Menlo Park, California. It offers genetic tests that analyze cell free DNA from a blood sample, using a sequencing method that counts individual DNA molecules. Its prenatal test, UNITY, assesses fetal genetic risk from a single maternal blood draw. Its Northstar tests are cancer tests used by oncology providers to help select treatments and track how patients respond to therapy.